Study guide
Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions
EBP-EAP Examination in Paediatrics Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Governance, Ethics & Child Safeguarding
EBP-EAP Format, Delivery, Scoring, and Clinical Vignette Strategy Paediatric Ethics, Consent/Assent, Gillick Competence, and Patient Safety Child Protection, Physical/Emotional Abuse, Neglect, and Non-Accidental Injury (NAI)
2 Chapter 2: Neonatal Transition, Resuscitation & Prematurity
Delivery Room Care, Apgar Scoring, and Neonatal Resuscitation Algorithm Respiratory Distress Syndrome (RDS), Surfactant Therapy, and Bronchopulmonary Dysplasia Perinatal Asphyxia, HIE Sarnat Staging, and Therapeutic Hypothermia Protocol
3 Chapter 3: Neonatal Morbidities, Jaundice & Congenital Infections
Unconjugated vs Conjugated Hyperbilirubinemia, Phototherapy Thresholds, and Exchange Transfusion Early- vs Late-Onset Sepsis, Group B Streptococcus, and Congenital TORCH Infections NEC Diagnosis/Bell Staging, Neonatal Hypoglycaemia, and Newborn Bloodspot Screening
4 Chapter 4: Acute Paediatric Emergencies & Critical Care
EPLS/PALS Structured Approach, Types of Shock, and Weight-Based Fluid Boluses Clinical Diagnostic Criteria, Intramuscular Adrenaline Dosing, and Refractory Anaphylaxis 5-Minute Time-Critical Anticonvulsant Protocol and Status Epilepticus Care Common Toxidromes (Paracetamol, Iron, Caustics, Button Batteries) and Decontamination
5 Chapter 5: Paediatric Respiratory Medicine
Stridor Differential, Croup (Westley Score & Dexamethasone), and Epiglottitis RSV Pathogenesis, Supportive Management, Oxygen/High-Flow Criteria, and Futility of Bronchodilators/Steroids European/BTS Guidelines on Chronic Stepwise Control and Acute Severe Exacerbation Management Community-Acquired Pneumonia Etiology, Parapneumonic Effusion/Empyema, and Cystic Fibrosis Pulmonary Exacerbations
6 Chapter 6: Paediatric Cardiology
Acyanotic vs Cyanotic Congenital Heart Disease: Ductal Patency, Shunt Lesions, and Emergency Stabilization Paediatric Murmurs and Arrhythmias: Innocent vs Pathological Murmurs, SVT, and Resuscitation Protocols Acquired Heart Disease: Kawasaki Disease, Coronary Aneurysm Prevention, and Acute Rheumatic Fever
7 Chapter 7: Paediatric Gastroenterology, Hepatology & Nutrition
Dehydration Severity Assessment, Oral Rehydration Therapy (ORT), and Intravenous Fluid Protocols ESPGHAN Coeliac Diagnostic Criteria (Biopsy-Sparing Pathway) and Paediatric Crohn's/Ulcerative Colitis Breastfeeding, Formula Selection, Cow's Milk Protein Allergy (CMPA), GERD vs GOR, and Faltering Growth Prolonged Neonatal Jaundice Workup, Biliary Atresia Red Flags, and Acute Hepatitis/Liver Failure
8 Chapter 8: Paediatric Nephrology, Fluids & Electrolyte Balance
Paediatric UTI Diagnosis, Imaging Criteria (Ultrasound/DMSA/MCUG), and Vesicoureteral Reflux Minimal Change Nephrotic Syndrome (Steroid Regimen & Complications) vs Acute Post-Infectious Glomerulonephritis Paediatric AKI (pRIFLE/KDIGO), Haemolytic Uraemic Syndrome (HUS), and Hyperkalaemia/Dysnatraemia Management
9 Chapter 9: Paediatric Endocrinology & Inborn Errors of Metabolism
Paediatric DKA Protocol (ISPAD/European Fluid & Insulin Guidelines, Cerebral Oedema Prevention) and T1DM Maintenance Congenital Hypothyroidism Screening & Levothyroxine, Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency), and Adrenal Crisis Short Stature Workup, Precocious vs Delayed Puberty, and Approach to Suspected Inborn Errors of Metabolism (IEM)
10 Chapter 10: Paediatric Neurology, Neurodevelopment & Mental Health
Simple vs Complex Febrile Seizures, Childhood Epilepsy Syndromes (Absence, Infantile Spasms, Benign Rolandic), and Antiseizure Medications Red Flags for Raised Intracranial Pressure (ICP), Brain Tumours, Migraine vs Tension Headache Acute Bacterial Meningitis (LP Contraindications, Ceftriaxone, Dexamethasone) and Viral Encephalitis (Aciclovir) Developmental Milestones (Gross Motor, Fine Motor/Vision, Speech/Language, Social), Autism Spectrum, ADHD, and Cerebral Palsy
11 Chapter 11: Paediatric Haematology & Oncology
Microcytic Anaemia (Iron Deficiency vs Thalassaemia Trait/Mentzer Index), Haemolytic Anaemias (Spherocytosis, G6PD) Sickle Cell Crises (Vaso-occlusive, Acute Chest Syndrome, Stroke Prevention), Immune Thrombocytopenia (ITP), and Haemophilia A/B Acute Lymphoblastic Leukaemia (ALL), Neuroblastoma, Wilms Tumour, and Management of Febrile Neutropenia
12 Chapter 12: Paediatric Infectious Diseases, Immunology & Allergy
Common Childhood Exanthems: Clinical Morphology, Timelines, Complications, and Management Paediatric Tuberculosis, Sepsis Six in Children, and Acute Osteoarticular Infections Pediatric Allergy, Atopic Eczema, Food Hypersensitivity, and Desensitization Primary Immunodeficiencies, Warning Signs, Live Vaccine Contraindications, and European Immunisation Schedules
13 Chapter 13: Paediatric Musculoskeletal, Dermatology & Surgical Conditions
The Limping Child, Septic Arthritis vs Transient Synovitis, and Juvenile Idiopathic Arthritis Henoch-Schönlein Purpura, Kawasaki Disease vs MIS-C, Infantile Haemangiomas, and Common Pediatric Eruptions Acute Appendicitis, Intussusception, Pyloric Stenosis, Testicular Torsion, and Incarcerated Hernia
14 Chapter 14: Research Methods, Biostatistics & Evidence-Based Paediatrics
Study Designs, Causality, Bias, and Epidemiological Measures in Paediatrics Diagnostic Test Accuracy, Statistical Inference, and Hypothesis Testing Systematic Reviews, Meta-Analysis, Decision Analysis, and Paediatric Research Ethics
15 Chapter 15: Paediatric Ophthalmology & ENT Disorders
Paediatric Vision Assessment, Refractive Disorders, Strabismus, and Leukocoria Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions
16 Chapter 16: Paediatric Sports Medicine & Musculoskeletal Health
Skeletal Maturity, Physeal Injuries, Apophysitis, and Overuse Syndromes Paediatric Sports Concussion, Second Impact Syndrome, and Return-to-Play Protocols Pre-Participation Screening, Physical Activity Guidelines, and Chronic Disease Clearance
17 Chapter 17: Adolescent Medicine & Healthcare Transition
Biopsychosocial Development, Pubertal Staging, and Adolescent Communication Adolescent Confidentiality, Risk Behaviours, Reproductive Health, and Eating Disorders Chronic Illness in Adolescence and Structured Healthcare Transition
18 Chapter 18: Paediatric Genetics, Dysmorphology & Clinical Genomics
Patterns of Inheritance, Non-Mendelian Mechanisms, and Pedigree Construction Clinical Dysmorphology, Chromosomal Aneuploidies, and Microdeletion Syndromes Genetic Testing Technologies, Prenatal Diagnosis, and Genetic Counselling Ethics
19 Chapter 19: Paediatric Mental Health, Behaviour & Community Medicine
Cognitive Development, Attachment, Screening, and Common Emotional Disorders Regulatory Disorders, Neurodevelopmental Behavioural Conditions, and Psychosomatic Illness Community Child Healthcare Structures, Disability Coordination, and Child Advocacy
Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions
Key Takeaways Explain This Topic AI
The paediatric Eustachian tube is shorter, wider, and oriented more horizontally (at approximately a 10-degree angle compared to 45 degrees in adults) with less rigid cartilage and immature tensor veli palatini function, predisposing infants and toddlers to middle ear negative pressure, fluid stasis, and ascending microbial contamination from the nasopharynx.
Acute Otitis Media (AOM) requires acute symptoms and middle ear effusion with tympanic membrane bulging. In the AAP framework, severe illness, otorrhoea or bilateral AOM at 6–23 months favour immediate antibiotics; selected non-severe cases can be observed with reliable 48–72-hour follow-up. Amoxicillin 80–90 mg/kg/day is the AAP first-line regimen; European national policies vary.
Otitis Media with Effusion (OME / 'glue ear') involves persistent non-purulent fluid without acute inflammation, producing conductive hearing loss, behavioral inattention, and expressive language delay; tympanometry typically demonstrates a flat Type B curve, and bilateral OME lasting >=3 months with hearing loss warrants hearing/functional assessment and discussion of grommets or hearing support, considering effects on daily life and family preferences.
Universal Newborn Hearing Screening (UNHS) utilizes a two-tier protocol of Transient Evoked Otoacoustic Emissions (TEOAE) to assess outer hair cell integrity and Automated Auditory Brainstem Response (AABR) to assess auditory nerve and brainstem pathway continuity; congenital cytomegalovirus (CMV) represents the most common non-genetic cause of sensorineural hearing loss (SNHL), while Connexin 26 (GJB2) mutations represent the most common genetic etiology.
Paediatric upper airway obstruction from adenotonsillar hypertrophy is the primary etiology of paediatric Obstructive Sleep Apnoea (OSA), associated with neurocognitive impairment and cardiovascular remodeling treatable by surgical adenotonsillectomy; paediatric epistaxis arises predominantly from Kiesselbach's plexus in Little's area on the anterior nasal septum, managed initially by firm digital compression with the head tilted forward, topical antiseptic barrier ointments, and chemical silver nitrate cautery.
Last updated: November 2026
Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions
Paediatric otolaryngological disorders represent a substantial proportion of primary care consultations and emergency presentations in childhood. Understanding the unique anatomical and physiological maturation of the paediatric craniomaxillofacial structures—most notably the Eustachian tube and pharyngeal lymphoid ring—is critical for managing otitis media, preventing developmental delays secondary to hearing impairment, and diagnosing life-threatening upper airway obstruction.
Anatomy and Physiology of the Paediatric Eustachian Tube
The Eustachian tube (pharyngotympanic tube) connects the middle ear cavity to the nasopharynx. Its fundamental physiological functions are: (1) middle ear pressure ventilation and equilibration, (2) mucociliary clearance of middle ear secretions into the nasopharynx, and (3) acoustic and functional protection against retrograde nasopharyngeal secretions and pathogen entry. [Eustachian Tube Comparison]
- Adult Anatomy Paediatric Anatomy
- Length: ~36 mm - Length: ~18 mm (half adult length)
- Angle: 45 degrees downward - Angle: ~10 degrees (almost horizontal)
- Rigid elastic cartilage - Soft, flaccid cartilage (high compliance)
- Robust tensor veli palatini angle - Less efficient active tensor dilation
- Protective against reflux - Facile retrograde reflux of secretions
- Anatomical Predispositions in Early Childhood
Length and Orientation : In infants and children under 7 years of age, the Eustachian tube is approximately half the adult length (18 mm vs 36 mm) and lies in an almost horizontal plane at an angle of approximately 10 ∘ 10^\circ 1 0 ∘ , compared to the steep 45 ∘ 45^\circ 4 5 ∘ downward incline in adults. This horizontal orientation significantly degrades gravitational drainage.
Cartilage Compliance : Paediatric tubal cartilage is softer, thinner, and structurally flaccid. It lacks the tensile rigidity required to prevent dynamic collapse under negative middle ear pressure.
Muscular Function : The active opening of the Eustachian tube during swallowing, yawning, or crying is mediated primarily by the tensor veli palatini muscle. In infants, the muscle fibers insert at an unfavorable mechanical angle into the tubal cartilage, resulting in inefficient active dilation.
Adenoidal Interaction : The pharyngeal tonsils ( adenoids ) are situated in close proximity to the pharyngeal ostium of the Eustachian tube (torus tubarius). Adenoid hypertrophy causes mechanical tubal obstruction, while chronic adenoiditis serves as a persistent bacterial biofilm reservoir ( S. pneumoniae , H. influenzae , M. catarrhalis ), seeding the middle ear.
Craniofacial and Environmental Risk Factors : Children with cleft palate (abnormal tensor veli palatini insertion into the hard palate), Down syndrome (hypotonia and midfacial hypoplasia), supine bottle feeding, exposure to passive household tobacco smoke, and group daycare attendance have exceptionally high incidences of tubal dysfunction and middle ear disease.
Acute Otitis Media (AOM)
Acute Otitis Media is an acute suppurative infectious process of the middle ear cleft, peaking in incidence between 6 and 18 months of age .
Microbial Etiology
Viral Priming : Upper respiratory tract viral infections (RSV, rhinovirus, influenza, parainfluenza, adenovirus, human metapneumovirus) precede bacterial AOM in over 80% of episodes. Viral replication induces nasopharyngeal inflammation, mucosal ciliary dyskinesia, and Eustachian tube obstruction, generating negative middle ear pressure that aspirates nasopharyngeal secretions.
Bacterial Pathogens :
Streptococcus pneumoniae : Gram-positive diplococci; accounts for 30% to 40% of cases. Although pneumococcal conjugate vaccines (PCV13, PCV15, PCV20) have reduced vaccine-serotype disease, non-vaccine serotypes frequently cause acute suppuration, high fevers, and suppurative complications.
Haemophilus influenzae : Non-typeable H. influenzae (NTHi) represents 40% to 50% of contemporary bacterial isolates. Approximately 30% to 40% of NTHi strains produce beta-lactamases . NTHi is characteristically associated with bilateral AOM and concurrent purulent conjunctivitis ( otitis-conjunctivitis syndrome ).
Moraxella catarrhalis : Gram-negative diplococci; accounts for 10% to 15% of cases. Over 90% produce beta-lactamases , though it is more prone to spontaneous clinical resolution.
Streptococcus pyogenes (Group A Streptococcus): Seen in older children; causes aggressive tympanic membrane necrosis and high mastoiditis rates.
Diagnostic Criteria
Under international and European consensus guidelines, a definitive diagnosis of AOM requires three concurrent elements:
Acute Onset : Rapid appearance of signs and symptoms of middle ear inflammation (ear pain, pulling/tugging at the ear, irritability, disturbed sleep, high fever).
Middle Ear Effusion (MEE) : Demonstrated via pneumatic otoscopy (absent or markedly reduced tympanic membrane motility) or tympanometry.
Distinct Tympanic Membrane Inflammation : Characterized by distinct, moderate-to-severe bulging of the tympanic membrane (the single most specific physical sign!), intense erythema, or acute spontaneous purulent otorrhoea.
Note
Isolated redness of the tympanic membrane without bulging or impaired pneumatic mobility is insufficient to diagnose AOM. Vigorous crying or high systemic fever routinely causes vascular engorgement and flushing of a completely normal tympanic membrane. [AOM Management: AAP Framework, Age >=6 Months]
- |
- +-----------------------------+-----------------------------+
- | |
- [IMMEDIATE ANTIBIOTICS] [OBSERVATION MAY BE CHOSEN]
- Otorrhoea or severe illness - Non-severe unilateral AOM at 6–23 mo
- Fever >=39 C or moderate/severe otalgia - Non-severe unilateral OR bilateral
- or otalgia lasting >=48 h AOM at >=24 mo
- Bilateral AOM at 6–23 mo - Reliable follow-up; start antibiotics
- High-risk children need individual assessment if worsening or not improving in 48–72 h
Analgesia for all. Infants <6 mo need prompt clinical assessment.
Antibiotic Stratification and Dosing
The doses below follow the AAP framework. NICE NG91 instead permits no, back-up or immediate antibiotics for selected children under 2 with bilateral AOM or those with otorrhoea; immediate antibiotics are indicated if systemically very unwell or at high risk of complications.
First-Line Antimicrobial : High-dose oral Amoxicillin at 80 to 90 mg/kg/day divided into two doses (maximum 2 to 3 g/day). High-dose amoxicillin achieves middle ear fluid concentrations exceeding the minimum inhibitory concentration (MIC) required to overcome penicillin-binding protein (PBP) mutations in intermediate- and highly resistant strains of Streptococcus pneumoniae .
Second-Line / Beta-Lactamase Coverage : Amoxicillin-clavulanic acid (Co-amoxiclav) at 90 mg/kg/day of the amoxicillin component with 6.4 mg/kg/day of clavulanate (a 14:1 ratio formulation designed to minimize clavulanate-induced diarrhea). Indicated when:
The child fails to improve after 48 to 72 hours of high-dose amoxicillin.
The child received amoxicillin within the preceding 30 days.
The child presents with concurrent purulent conjunctivitis (otitis-conjunctivitis syndrome, highly predictive of beta-lactamase-producing NTHi).
Duration of Therapy : 10 days for children < 2 <2 < 2 years or severe disease; for mild-to-moderate illness, 7 days at ages 2–5 and 5–7 days at ages >=6 years.
Suppurative Complications :
Acute Mastoiditis : Spread of middle ear infection into the mastoid air cells, causing osteitis and periosteal breakdown. Clinically characterized by postauricular erythema, fluctuant swelling, tenderness, obliteration of the retroauricular crease, and anterior-inferior protrusion (proptosis) of the auricle . Mandates immediate hospital admission, IV broad-spectrum antibiotics (IV ceftriaxone), and emergency ENT evaluation.
Other Complications : Subperiosteal abscess (Bezold's abscess in the sternocleidomastoid, Luc's abscess), facial nerve palsy (CN VII neuropraxia), acute suppurative labyrinthitis, and intracranial spread (meningitis, epidural/brain abscess, sigmoid lateral sinus thrombosis).
Otitis Media with Effusion (OME / 'Glue Ear')
Otitis Media with Effusion denotes the presence of non-purulent fluid collection within the middle ear cleft without accompanying signs or symptoms of acute systemic illness or acute tympanic membrane inflammation .
Natural History and Clinical Consequences
Epidemiology : OME affects up to 80% to 90% of children before school entry, peaking at ages 2 and 5 years . Over 75% of episodes resolve spontaneously within 3 months .
Clinical Presentation : Unlike AOM, OME produces no acute fever or otalgia. Instead, it manifests with insidious, fluctuating conductive hearing loss (typically 20 to 40 dB HL). Parents and teachers report frequent requests for repetition, high television volume, behavioral inattention, speech clarity deterioration, and expressive language developmental delay.
Otoscopic Findings : Tympanic membrane is retracted or in a neutral position, exhibiting a dull, yellowish, amber, or pearly-grey discoloration; prominent lateral process and shortened handle of the malleus; loss of the normal cone of light; and visible air-fluid levels or intratympanic fluid bubbles. [Jerger Tympanometric Curves: Schematic]
- Type A: normal Type B: flat Type C: negative pressure
- Compliance Compliance Compliance
- ^ ^ ^
- | /\ | | /\
- |___/ \___ |__________ |/ \_______
- 200 0 +200 -200 0 +200 -200 0 +200
- Peak near 0 daPa No distinct peak Peak below −150 daPa
Pressure axis in daPa; Type B interpretation also requires ear-canal volume.
Tympanometry Interpretation (Jerger Classification)
Type A : Normal middle ear aeration and compliance. Peak occurs near atmospheric pressure ( − 100 -100 − 100 to + 100 +100 + 100 daPa).
Type B (Flat Curve) :
Normal Canal Volume (0.3 to 1.0 mL) : Diagnostic of middle ear fluid (OME) or severe membrane thickening. The fluid column resists acoustic admittance.
Large Canal Volume ( > 1.5 >1.5 > 1.5 to 2.0 mL) : Diagnostic of a tympanic membrane perforation or a patent tympanostomy tube (grommet) , where the instrument measures middle ear plus canal volume.
Type C : Compliance peak shifted significantly into negative pressure ( < − 150 <-150 < − 150 to − 200 -200 − 200 daPa). Reflects Eustachian tube dysfunction; it does not alone confirm or exclude middle ear fluid, so correlate with otoscopy.
Grommet (Tympanostomy Tube) Indications
Antihistamines, decongestants, systemic/intranasal corticosteroids and antibiotics are not recommended for OME.
For bilateral OME persisting >=3 months with hearing loss , discuss the effects on communication, learning and daily life. Consider grommets through shared decision-making; hearing aids, listening support and, if the child can engage, autoinflation are alternatives. Earlier intervention may be needed when hearing difficulty substantially affects daily life.
In children at developmental risk (e.g., Down syndrome, cleft palate, existing SNHL or developmental/language difficulties), AAO guidance permits tubes when OME is likely to persist, indicated by a flat Type B tympanogram or documented effusion for >=3 months; risk status alone is not an automatic indication.
Recurrent AOM may justify tubes at >=3 episodes in 6 months or >=4 in 12 months (at least one in the preceding 6 months); offer tubes only if middle ear effusion is present at the candidacy assessment.
Structural Changes : Deep tympanic retraction pockets or ossicular erosion warrant specialist assessment to prevent cholesteatoma and lasting damage.
Adenoidectomy : AAO guidance permits adjunctive adenoidectomy at >=4 years, or earlier for nasal obstruction/chronic adenoid disease. NICE advises considering it with grommets unless there is a palatal abnormality. Discuss the applicable national policy and risks.
Benefits and Risks : Tubes can improve hearing while functioning, but benefit is not guaranteed or permanent. Discuss otorrhoea, tympanosclerosis and persistent perforation; reassess hearing after surgery.
Childhood Hearing Impairment: UNHS and Etiological Evaluation
Permanent childhood hearing loss occurs in 1 to 2 per 1,000 live births. Early audiological habilitation within the first 6 months of life is decisive for normal cortical auditory pathway wiring and spoken language acquisition.
Universal Newborn Hearing Screening (UNHS): The 1-3-6 Benchmark
International guidelines mandate the 1-3-6 target :
- Screening by 1 month of age
- Audiological diagnostic confirmation by 3 months of age
Initiation of intervention (hearing aids, speech therapy) by 6 months of age [Universal Newborn Hearing Screening]
- |
- +--------------------------+--------------------------+
- | |
- [Well-Baby Nursery] [NICU Graduates (>48h)]
- Transient Evoked Otoacoustic Emissions (TEOAE) - Automated Auditory Brainstem
- Measures outer hair cell micromechanics Response (AABR) MANDATORY
- Quick, sensitive to cochlear deafness - Detects neural dyssynchrony and
- Fails to detect auditory neuropathy Auditory Neuropathy Spectrum (ANSD)
Transient Evoked Otoacoustic Emissions (TEOAE) : A miniature probe in the ear canal delivers acoustic clicks and measures sound waves generated by the electromotile outer hair cells of the organ of Corti . A 'pass' shows detectable outer-hair-cell responses under screening conditions; it does not establish a diagnostic hearing threshold or exclude all hearing loss. However, TEOAE cannot evaluate neural pathways beyond the cochlea ; an infant with intact cochlear hair cells but total auditory nerve disruption will erroneously register a normal 'pass'.
Automated Auditory Brainstem Response (AABR) : Surface scalp electrodes measure electrophysiological neural activity (specifically Wave V) generated from the cochlear nerve and brainstem auditory nuclei in response to acoustic stimuli. AABR is mandatory for all NICU graduates (infants with gestational age < 32 <32 < 32 weeks, severe perinatal asphyxia, ECMO, hyperbilirubinemia requiring exchange transfusion, or ototoxic drug exposure) because these high-risk neonates have a high prevalence of Auditory Neuropathy Spectrum Disorder (ANSD) .
Sensorineural Hearing Loss (SNHL): Etiologies
Classification Specific Etiology Molecular / Pathological Basis Key Clinical Manifestations & Diagnostic Features
Congenital Infection Congenital Cytomegalovirus (cCMV) Transplacental viral replication damaging inner ear vascular stria and hair cells. Most common non-genetic cause of childhood SNHL . Loss can be unilateral or bilateral, fluctuating, progressive, or late-onset. Test urine/saliva CMV PCR within 21 days; confirm positive saliva with urine PCR. Significant symptomatic disease warrants specialist antiviral treatment.
Genetic (Non-syndromic, 70%) GJB2 Gene Mutation (Connexin 26) Autosomal recessive defect in gap-junction beta-2 protein disrupting potassium recycling in cochlea. Most common genetic cause of severe-to-profound congenital SNHL (up to 50% of recessive non-syndromic cases). Normal inner ear anatomy on CT/MRI; excellent outcomes with cochlear implantation.
Genetic (Syndromic, 30%) Pendred Syndrome Autosomal recessive mutation in SLC26A4 encoding pendrin anion exchanger. Bilateral progressive SNHL, enlarged vestibular aqueduct (EVA) on temporal CT, and adolescent euthyroid multinodular goiter (positive perchlorate discharge test).
Genetic (Syndromic) Jervell and Lange-Nielsen Autosomal recessive mutations in KCNQ1 or KCNE1 potassium channel genes. Congenital bilateral profound SNHL accompanied by pathological prolongation of the QT interval ( Q T c > 500 QT_c > 500 Q T c > 500 ms) on ECG. Extremely high risk of polymorphic ventricular tachycardia ( Torsades de Pointes ) and sudden cardiac death during emotional/exercise stress. Mandatory screening ECG in all children with unexplained congenital SNHL!
Genetic (Syndromic) Usher Syndrome Multiple autosomal recessive genes ( MYO7A , USH2A ). Sensorineural hearing impairment combined with progressive visual loss from retinitis pigmentosa (night blindness, peripheral visual field tunnel constriction).
Acquired / Toxic Aminoglycoside Ototoxicity Mitochondrial mutation m.1555A>G in the MTRNR1 gene (12S rRNA). Individuals carrying this maternally inherited mutation develop rapid, permanent, bilateral cochlear hair cell necrosis even after a single conventional therapeutic dose of gentamicin, tobramycin, or amikacin.
Acquired / Post-Infectious Bacterial Meningitis Suppurative labyrinthitis secondary to meningococcal or pneumococcal infection. Leads to rapid labyrinthitis ossificans (fibro-osseous obliteration of the fluid-filled cochlear scalae). Mandates urgent serial audiometry and immediate cochlear implant candidacy evaluation before complete osseous lumen obliteration occurs.
- Upper Airway Conditions: Recurrent Tonsillitis, OSA, and Epistaxis
- Recurrent Acute Tonsillitis: The Paradise Criteria
For recurrent throat infection, the Paradise criteria identify children in whom tonsillectomy may be offered after discussing benefits and risks. Other indications include OSA; modifying factors such as PFAPA, antibiotic intolerance or recurrent peritonsillar abscess may also support surgery. [The Paradise Criteria for Tonsillectomy]
- Frequency Thresholds:
- * >=7 episodes in the preceding 12 months; OR
- * >=5 episodes per year for each of the preceding 2 consecutive years; OR
- * >=3 episodes per year for each of the preceding 3 consecutive years
- +
- Documented Clinical Features (for each episode):
- * Fever >=38.3 °C (101 °F); OR
- * Cervical lymphadenopathy (tender or >2 cm); OR
- * Tonsillar exudate; OR
- * Positive swab / RADT for Group A Streptococcus
- +
- Adequate Medical Therapy:
- * Appropriate antimicrobials for proven or suspected streptococcal episodes
- Paediatric Obstructive Sleep Apnoea (OSA)
Pathophysiology : Sleep-induced loss of upper airway neuromuscular tone superimposed upon anatomical upper airway narrowing. In children aged 2 to 8 years, the predominant anatomical driver is adenotonsillar hypertrophy .
Clinical Signs : Habitual loud snoring, witnessed nocturnal pauses, gasping, choking, paradoxical inward thoracic motion during inspiration, restless sleep in hyperextended neck postures, morning headaches, secondary daytime enuresis, and neurobehavioral daytime morbidity (hyperactivity, impulsivity, poor school attention mimicking ADHD). Severe, longstanding OSA induces chronic alveolar hypoventilation, pulmonary vasoconstriction, pulmonary arterial hypertension, and cor pulmonale .
Diagnostic Gold Standard : In-laboratory overnight Polysomnography (PSG) . Paediatric OSA is defined as an Apnoea-Hypopnoea Index (AHI) >=1 event per hour (mild: AHI 1 to < 5 <5 < 5 ; moderate: AHI 5 to < 10 <10 < 10 ; severe: AHI >=10 events/hr).
Management : Surgical adenotonsillectomy is the definitive first-line therapeutic intervention in otherwise healthy children with adenotonsillar hypertrophy, demonstrating marked resolution of airway obstruction and behavioral improvement in > 80 % >80\% > 80% of patients.
Paediatric Epistaxis
Vascular Anatomy : Over 90% of childhood epistaxis originates on the anterior-inferior nasal septum at Little's area , corresponding to Kiesselbach's plexus . This is a rich, fragile submucosal arterial anastomosis formed by five vessels: (1) Anterior ethmoidal artery, (2) Posterior ethmoidal artery, (3) Sphenopalatine artery, (4) Greater palatine artery, and (5) Superior labial artery (septal branch).
First-Aid Protocol : The child must sit completely upright with the head tilted slightly forward (never backward, which directs blood into the hypopharynx, causing gastric irritation, vomiting, and aspiration risk). Firm, continuous digital pressure must be applied to the soft, compressible anterior lower third of the nose (nasal alae) for a continuous 10 to 15 minutes without releasing pressure to inspect.
Medical Therapy & Cautery :
Topical Antiseptics : Naseptin cream (chlorhexidine and neomycin; current formulation is arachis-oil-free—check allergy to its ingredients) or mupirocin applied twice daily for 2 to 4 weeks eradicates S. aureus vestibulitis and allows re-epithelialization.
Chemical Cautery : Silver nitrate (75%) applicators applied under topical local anesthesia to prominent, bleeding septal vessels.
Caution
Never perform bilateral simultaneous silver nitrate chemical cautery at the same opposing levels of the nasal septum . Bilateral cauterization destroys mucosal perichondrial blood supply from both sides, producing ischemic necrosis of the septal cartilage and leading to permanent nasal septal perforation .
Red Flags for Neoplasm or Bleeding Diathesis :
Coagulopathies : Spontaneous, recurrent, bilateral epistaxis, gingival bleeding, petechiae, or hemarthroses warrants screening for von Willebrand disease, immune thrombocytopenia (ITP), or hemophilia.
Juvenile Nasopharyngeal Angiofibroma (JNA) : A benign but locally aggressive, non-capsulated, richly vascular tumor arising in the sphenopalatine foramen, occurring almost exclusively in adolescent males (aged 10 to 18 years) . Presents with recurrent, unprovoked, massive unilateral epistaxis and progressive unilateral nasal obstruction. Biopsy in an outpatient setting is ABSOLUTELY CONTRAINDICATED due to catastrophic, life-threatening hemorrhage. Diagnosis mandates contrast CT/MRI and diagnostic angiography.